Abstract
Determining the impact of rovatirelin which is a thyrotropin-releasing hormone in the treatment of ataxias in spinocerebellar degenerations
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
